PLAU and atherosclerosis: Urokinase-type plasminogen activator has been shown to be expressed at elevated levels in macrophages from arterial lesions in atherosclerosis [44] and lesion associated expression of its receptor (uPAR, CD87) has been documented in humans with CM [45].